sintilimab,bevacizumab
eli lilly,innovent biologics,roche
['sintilimab', 'bevacizumab']
dr qinglei gao:
preliminary results from multicenter, single-arm, phase ii trial have shown that sintilimab and bevacizumab combination therapy as a chemo-free regimen exhibits promising efficacy and favorable safety in patients with recurrent/persistent occc. #esmo2022
Flagship #OpenAccess medical journal from @BioMedCentral. Publishes research articles & reviews in all areas of research & practice in #medicine & #globalhealth